Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Cell
|
December 20, 2014
Acetate is a bioenergetic substrate for human glioblastoma and brain metastases
Tomoyuki Mashimo, Kumar Pichumani, Vamsidhara Vemireddy, et al.
Nature Medicine
|
January 28, 2012
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas
Changho Choi, Sandeep K Ganji, Ralph J DeBerardinis, et al.
NMR in Biomedicine
|
March 3, 2012
Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors
Isaac Marin-Valencia, Steve K Cho, Dinesh Rakheja, et al.
NMR in Biomedicine
|
November 25, 2025
Magnetic Resonance Spectroscopy of Cystathionine and 2-Hydroxyglutarate in Brain Tumors
Changho Choi, Mai Huynh, Zoltan Kovacs, et al.
Nature Medicine
|
February 24, 2023
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
Ingo K Mellinghoff, Min Lu, Patrick Y Wen, et al.
Cell Reports
|
January 26, 2017
Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma
Dinesh K Singh, Rahul K Kollipara, Vamsidara Vemireddy, et al.
Cell Metabolism
|
June 12, 2012
Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo
Isaac Marin-Valencia, Chendong Yang, Tomoyuki Mashimo, et al.
NMR in Biomedicine
|
September 30, 2025
Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate and Glycine in Adult Subjects With Brainstem Gliomas
Vivek Tiwari, Sandeep K Ganji, Zhongxu An, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2021
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
Ingo K Mellinghoff, Marta Penas-Prado, Katherine B Peters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2017
Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma
Changho Choi, Jack M Raisanen, Sandeep K Ganji, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Cell
|
December 20, 2014
Acetate is a bioenergetic substrate for human glioblastoma and brain metastases
Tomoyuki Mashimo, Kumar Pichumani, Vamsidhara Vemireddy, et al.
Nature Medicine
|
January 28, 2012
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas
Changho Choi, Sandeep K Ganji, Ralph J DeBerardinis, et al.
NMR in Biomedicine
|
March 3, 2012
Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors
Isaac Marin-Valencia, Steve K Cho, Dinesh Rakheja, et al.
NMR in Biomedicine
|
November 25, 2025
Magnetic Resonance Spectroscopy of Cystathionine and 2-Hydroxyglutarate in Brain Tumors
Changho Choi, Mai Huynh, Zoltan Kovacs, et al.
Nature Medicine
|
February 24, 2023
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
Ingo K Mellinghoff, Min Lu, Patrick Y Wen, et al.
Cell Reports
|
January 26, 2017
Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma
Dinesh K Singh, Rahul K Kollipara, Vamsidara Vemireddy, et al.
Cell Metabolism
|
June 12, 2012
Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo
Isaac Marin-Valencia, Chendong Yang, Tomoyuki Mashimo, et al.
NMR in Biomedicine
|
September 30, 2025
Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate and Glycine in Adult Subjects With Brainstem Gliomas
Vivek Tiwari, Sandeep K Ganji, Zhongxu An, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2021
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
Ingo K Mellinghoff, Marta Penas-Prado, Katherine B Peters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2017
Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma
Changho Choi, Jack M Raisanen, Sandeep K Ganji, et al.
Page
of 6